Dec 2012 $28 M No. 3 $10 to $50 million 9
Crescendo Bioscience, Inc.: Raise no. 3, Dec 2012 × Investors in this round 9 investors had bought by the notice of Jan 2, 2013: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $28 M of $28 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Sale and issuance of (i) Series D Preferred Stock, (ii) Warrants, (iii) Series D Preferred Stock underlying Warrants and (iv) Common Stock issuable upon conversion of Series D Preferred Stock.
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $1,179,400
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Timothy G. Henn · Executive Officer William A. Hagstrom · Executive Officer, Director Brook G. Byers · Director Gary G. Kurtzman · Director George G. Rehm · Director Jack G. Oliver · Director Josh G. Green · Director Larry G. Leisure · Director Leon G. Chen · Director Ralph G. Snyderman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round William J. Kridel (CRD 704171) · broker-dealer FERGHANA SECURITIES, INC. (CRD 43430) · New York, New York Sold in all US states, and outside the US A. Rawle Michelson (CRD 1507251) · broker-dealer FERGHANA SECURITIES, INC. (CRD 43430) · New York, New York Sold in all US states, and outside the US E. Hunterson Herie (CRD 2431896) · broker-dealer FERGHANA SECURITIES, INC. (CRD 43430) · New York, New York Sold in all US states, and outside the US Remarks in the notice On fees: “The finders' fees contain $940,000 cash plus warrants”On the amounts: “Total Offering and Sales Amounts assume the exercise of warrants ($454,396.01)”Signed by Timothy G. Henn, Secretary. Source: SEC Form D, newest notice filed Jan 2, 2013. Read the notice at the SEC .
equity, options SEC Sep 2011 $25 M Issued in a merger or acquisition $10 to $50 million 1
Crescendo Bioscience, Inc.: Private sale, Sep 2011 × Investors in this round 1 investor had bought by the notice of Sep 20, 2011: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $25 M of $25 M offered
Smallest investment taken no minimum stated
What was sold equity, debt, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice William A. Hagstrom · Executive Officer, Director William R. Salisbury · Executive Officer Brook R. Byers · Director George R. Rehm · Director Jack R. Oliver · Director Larry R. Leisure · Director Ralph R. Snyderman · Director Sue R. Siegel · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by William R. Salisbury, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 20, 2011. Read the notice at the SEC .
equity, debt SEC Jun 2011 $31 M No. 2 $10 to $50 million 10
Crescendo Bioscience, Inc.: Raise no. 2, Jun 2011 × Investors in this round 10 investors had bought by the notice of Jun 20, 2011: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $31 M of $40 M offered; $9 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Sale and issuance of Series C Preferred Stock and the underlying Common Stock issuable upon conversion thereof.
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice William A. Hagstrom · Executive Officer, Director William R. Salisbury · Executive Officer Brook R. Byers · Director George R. Rehm · Director Jack R. Oliver · Director Larry R. Leisure · Director Ralph R. Snyderman · Director Sue R. Siegel · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by William R. Salisbury, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 20, 2011. Read the notice at the SEC .
equity SEC Jun 2008 $38 M No. 1 $10 to $50 million 4
Crescendo Bioscience, Inc.: Raise no. 1, Jun 2008 × Investors in this round 4 investors had bought by the notice of Jul 7, 2010: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $38 M of $43 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Sale and issuance of Series B Preferred Stock and the underlying Common Stock issuable upon conversion thereof.
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $1,200,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Amy R. Paye · Executive Officer William A. Hagstrom · Executive Officer, Director William R. Salisbury · Executive Officer Brook R. Byers · Director Jack R. Oliver · Director Larry R. Leisure · Director Sue R. Siegel · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “This estimate excludes amounts paid and that may be paid to the law firms with which one of the executive officers was or is affiliated.”Signed by William R. Salisbury, Chief Financial Officer. Source: SEC Form D and 2 amendments, newest notice filed Jul 7, 2010. Read the notice at the SEC .
equity SEC